Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review. [PDF]
Shono A, Hoshi SL, Kondo M.
europepmc +1 more source
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children [PDF]
Lorenzo Lodi +12 more
openalex +1 more source
Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea. [PDF]
Choe YJ +11 more
europepmc +1 more source
Invasive Pneumococcal Disease (IPD) in Children and Adults Following Introduction of Pneumococcal Conjugate Vaccines: Data From Population Based Surveillance 2001–2015 [PDF]
Allison McGeer +5 more
openalex +1 more source
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants. [PDF]
Pichon S +12 more
europepmc +1 more source
Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era. [PDF]
Yee ME +10 more
europepmc +1 more source
Vaccination with conjugate vaccines against pneumococcal disease: What really matters
José Cássio de Moraes +6 more
openalex +1 more source
Neutrophils induce effective antibody responses to the pneumococcal conjugate vaccine by inhibiting regulatory T cells [PDF]
Essi Y. I. Tchalla +7 more
openalex +1 more source
Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review. [PDF]
Yewale V +4 more
europepmc +1 more source
Cost-effectiveness of a 13-valent pneumococcal conjugate vaccine compared with currently available pneumococcal conjugate vaccines in Indian children. [PDF]
Taur SR +6 more
europepmc +1 more source

